Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to the big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger https://waltm257kex3.blogofchange.com/profile